Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
BeOne Medicines AG (NASDAQ: ONC)
ONC Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-39.50%
Analyst Rating:
BUY
Analyst Forecast (1yr):
38.30%
ONC Stock Analysis
ONC
PE Ratio:
845.5
ONC
PEG Ratio:
19.7
ONC
Forward EPS Growth (12 month):
43.00%
ONC
PS Ratio:
5.2
ONC
PSG Ratio:
0.4
ONC
Forward Revenue Growth (12 month):
14.80%
ONC Articles
No data was found